An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (235)
  • Training (0)
  • User case (4)
  • User meeting (1)
  • Webinar (13)
  • White paper (2)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • (-) Gastro-intestinal (125)
  • Genito-urinary (51)
  • Gynecological (7)
  • (-) Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • Ocular (12)
  • Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)
  • Reset filters
  • (-) Gastro-intestinal
  • (-) Head and neck

Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.

08/09/2018
/ Publications
/
Quality of life

A study by the Seattle group analyzed 231 patients of localized prostate cancer treated with protons. Median follow-up was 1.7 years. Grade 3 toxicity was seen...

Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy.

08/07/2018
/ Publications
/
Toxicity

A retrospective analysis on 100 patients' acute and late genitourinary (GU) and gastrointestinal (GI) toxicities associated with post-prostatectomy proton...

Cost effectiveness of prostate cancer radiotherapy.

08/06/2018
/ Publications
/
IMRT
Hypofractionation

This review article by Konski A, examined the data of cost-effectiveness analyses of various radiotherapy modalities including 3DCRT, IMRT, hypofractionated RT...

Proton therapy for hepatocellular carcinoma (HCC): Current knowledges and future perspectives.

08/07/2018
/ Publications

A review by the Samsung Medical Center, Korea on radiotherapy for HCC, discussed the physical properties, current clinical data, technical issues, and future...

Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation.

08/08/2018
/ Publications
/
IMRT
Chemotherapy

This MD Anderson study compared IMRT and PBT chemoradiation for esophageal cancer. Patients who had IMRT and PBT matched by propensity score (n = 220) were not...

Finding Value for Protons: The Case of Prostate Cancer?

05/04/2018
/ Publications
/
Dosimetry
Quality of life

A review by UPenn examined the dosimetric data and clinical outcome reports. Clinical studies largely suggest no difference in urinary side effects or erectile...

Minimal toxicity after PBT for prostate and pelvic nodal irradiationresults, proton collaborative group REG001-09 trial.

11/10/2017
/ Publications
/
Toxicity

This PCG study evaluated toxicity outcomes for non-metastatic prostate cancer patients who received pelvic radiation therapy.

The study demonstrated PBT...

Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer.

11/12/2017
/ Publications
/
Chemotherapy

Compared the relative risk of radiation-induced lymphopenia between IMRT and PBT in esophageal cancer (EC) patients undergoing neoadjuvant chemoradiation...

Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.

03/03/2017
/ Publications
/
Toxicity

Published in the Green Journal, the researchers in Japan reported outcomes of 83 patients treated with definitive repeated PBT. Patients received a median doses...

Establishing evidence-based indications for proton therapy.

10/11/2016
/ Publications
/
Clinical Trial
PT101

An overview of current clinical trials of proton therapy published in the Red Journal. A total 122 ongoing trials with target enrolment of over 42,000 patients...

Pagination

  • Previous page ‹
    • Page 20
    • Current page 21
    • Page 22
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies